IPP Bureau
GenWorks introduces mechanical hysteroscopic tissue removal system
By IPP Bureau - July 28, 2023
Uses a simple mechanical approach for removing intrauterine tissues
Cipla reports jump in Q1FY24 consolidated PAT to Rs. 995.70 Cr
By IPP Bureau - July 27, 2023
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Eugia Pharma receives USFDA approval for Plerixafor Injection
By IPP Bureau - July 26, 2023
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
TransCure bioServices partners with Preclina to expands reach into APAC
By IPP Bureau - July 26, 2023
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Teva Pharmaceuticals engages Honeywell to help reduce carbon impact
By IPP Bureau - July 26, 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
InnoCare gets approval of clinical trial of Zurletrectinib for the treatment of pediatric patients in China
By IPP Bureau - July 26, 2023
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Robotic surgery enhances success rate in knee replacements
By IPP Bureau - July 26, 2023
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Akums gets approval for triple combination diabetes treatment
By IPP Bureau - July 26, 2023
Syngene Q1 FY 2024 revenue up 26% to Rs. 832 crores, PAT up 26% to Rs.93 Cr
By IPP Bureau - July 26, 2023
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Adlib and Generis launch software connector to increases automation and compliant management of document repositories
By IPP Bureau - July 26, 2023
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
Lupin receives approval from TGA Australia for Tiotropium Dry Powder
By IPP Bureau - July 26, 2023
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
NATCO files generic Erdafitinib Tablets in USA
By IPP Bureau - July 26, 2023
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Jubilant Ingrevia consolidated Q1 FY2024 PAT up QoQ at Rs. 57.59 Cr
By IPP Bureau - July 26, 2023
Jubilant Ingrevia has reported total income of Rs. 1083.52 crores during the period ended June 30, 2023
AstraZeneca India receives permission from DCGI for Dapagliflozin
By IPP Bureau - July 25, 2023
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
